IL6R |
IL6R: Interleukin-6 receptor alpha chain precursor |
OSM |
OSM: Oncostatin-M precursor |
1.132 |
Evidence |
|
LNK |
SH2B3, LNK: SH2B adapter protein 3 |
SRC |
SRC, SRC1: Proto-oncogene tyrosine-protein kinase Src |
1.132 |
Evidence |
|
CASP1 |
CASP1, IL1BC, IL1BCE: Caspase-1 precursor |
RIPK1 |
RIPK1, RIP: Receptor-interacting serine/threonine-protein kinase 1 |
1.132 |
Evidence |
|
PLAT |
PLAT: Tissue-type plasminogen activator precursor |
SERPINA5 |
SERPINA5, PCI, PLANH3, PROCI: Plasma serine protease inhibitor precursor |
1.132 |
Evidence |
|
CASP9 |
CASP9, MCH6: Caspase-9 precursor |
TRADD |
TRADD: Tumor necrosis factor receptor type 1-associated DEATH domain protein |
1.132 |
Evidence |
|
OSM |
OSM: Oncostatin-M precursor |
IL4R |
IL4R, 582J2.1, IL4RA: Interleukin-4 receptor alpha chain precursor |
1.132 |
Evidence |
|
CCR2 |
CCR2, CMKBR2: C-C chemokine receptor type 2 |
GNA13 |
GNA13: Guanine nucleotide-binding protein alpha-13 subunit |
1.132 |
Evidence |
|
FN1 |
IPI00339223 |
EFNB1 |
EFNB1, EFL-3, EPLG2, LERK2: Ephrin-B1 precursor |
1.132 |
Evidence |
|
PTK2 |
PTK2, FAK, FAK1: Focal adhesion kinase 1 |
SLA2 |
SLA2, C20orf156, SLAP2: Src-like-adapter 2 |
1.132 |
Evidence |
|
HLA-G |
HLA-G, HLA-6.0, HLAG: HLA class I histocompatibility antigen, alpha chain G prec |
AZGP1 |
AZGP1, tcag7.638: Alpha-2-glycoprotein 1, zinc-binding |
1.132 |
Evidence |
|
TEC |
TEC, PSCTK4: Tyrosine-protein kinase Tec |
SLA2 |
SLA2, C20orf156, SLAP2: Src-like-adapter 2 |
1.132 |
Evidence |
|
FYN |
FYN: Proto-oncogene tyrosine-protein kinase Fyn |
PLCG1 |
PLCG1, PLC1: 1-phosphatidylinositol-4,5-bisphosphate phosphodiesterase gamma-1 |
1.132 |
Evidence |
O
|
TESK1 |
TESK1: Dual specificity testis-specific protein kinase 1 |
SLA2 |
SLA2, C20orf156, SLAP2: Src-like-adapter 2 |
1.132 |
Evidence |
|
PTAFR |
PTAFR, PAFR: Platelet-activating factor receptor |
GNAI2 |
Galphai2 protein |
1.132 |
Evidence |
|
HCK |
IPI00029769 |
SLA2 |
SLA2, C20orf156, SLAP2: Src-like-adapter 2 |
1.132 |
Evidence |
|
TRPV6 |
TRPV6, ECAC2: Transient receptor potential cation channel subfamily V member 6 |
TRPV1 |
TRPV1: Vanilloid receptor variant TRPV1b |
1.132 |
Evidence |
|
PTPN6 |
PTPN6, HCP, PTP1C: Tyrosine-protein phosphatase non-receptor type 6 |
PTK2 |
PTK2, FAK, FAK1: Focal adhesion kinase 1 |
1.132 |
Evidence |
|
HAND1 |
HAND1, EHAND: Heart- and neural crest derivatives-expressed protein 1 |
HES6 |
HES6: Transcription cofactor HES-6 |
1.132 |
Evidence |
|
INSL3 |
JAK3: Tyrosine-protein kinase JAK3 |
ITK |
ITK, EMT, LYK: Tyrosine-protein kinase ITK/TSK |
1.132 |
Evidence |
|
HLA-C |
HLA-C, HLAC: HLA class I histocompatibility antigen, Cw-7 alpha chain precursor |
AZGP1 |
AZGP1, tcag7.638: Alpha-2-glycoprotein 1, zinc-binding |
1.132 |
Evidence |
|
AHR |
AHR: Aryl hydrocarbon receptor precursor |
NCOA3 |
NCOA3, AIB1, RAC3, TRAM1: Nuclear receptor coactivator 3 |
1.132 |
Evidence |
|
IFNG |
IFNG: Interferon gamma precursor |
IL12B |
IL12B, NKSF2: Interleukin-12 subunit beta precursor |
1.132 |
Evidence |
|
TFAP4 |
TFAP4: Transcription factor AP-4 |
HIF1A |
HIF1A, MOP1: Hypoxia-inducible factor 1 alpha |
1.132 |
Evidence |
|
TCF3 |
TCF3, E2A, ITF1: Transcription factor E2-alpha |
HES6 |
HES6: Transcription cofactor HES-6 |
1.132 |
Evidence |
|
MATK |
MATK, CTK, HYL: Megakaryocyte-associated tyrosine-protein kinase |
LNK |
SH2B3, LNK: SH2B adapter protein 3 |
1.132 |
Evidence |
|